X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with BAJAJ CORP - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BAJAJ CORP - Comparison Results

BAJAJ CORP 
   Change

Bajaj Corp. Limited (BCL) is a leading producer of hair oils. It is part of the Shishir Bajaj Group of companies and subsidiary of Bajaj Consumer Care Limited (BCCL). The legacy of BCL began in 1953 when Bajaj Sevashram was established to market and ... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BAJAJ CORP AMAR REMEDIES/
BAJAJ CORP
 
P/E (TTM) x -0.5 28.4 - View Chart
P/BV x 0.1 12.4 0.5% View Chart
Dividend Yield % 0.0 2.9 -  

Financials

 AMAR REMEDIES   BAJAJ CORP
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BAJAJ CORP
Mar-18
AMAR REMEDIES/
BAJAJ CORP
5-Yr Chart
Click to enlarge
High Rs164520 31.5%   
Low Rs86343 25.1%   
Sales per share (Unadj.) Rs261.656.2 465.8%  
Earnings per share (Unadj.) Rs17.414.3 121.5%  
Cash flow per share (Unadj.) Rs22.314.8 150.5%  
Dividends per share (Unadj.) Rs012.00 0.0%  
Dividend yield (eoy) %02.8 0.0%  
Book value per share (Unadj.) Rs100.733.4 301.7%  
Shares outstanding (eoy) m26.16147.50 17.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.7 6.2%   
Avg P/E ratio x7.230.1 23.8%  
P/CF ratio (eoy) x5.629.1 19.3%  
Price / Book Value ratio x1.212.9 9.6%  
Dividend payout %083.9 0.0%   
Avg Mkt Cap Rs m3,27063,609 5.1%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m163771 21.1%   
Avg. sales/employee Rs ThNM7,351.3-  
Avg. wages/employee Rs ThNM683.9-  
Avg. net profit/employee Rs ThNM1,872.9-  
INCOME DATA
Net Sales Rs m6,8448,285 82.6%  
Other income Rs m21244 8.6%   
Total revenues Rs m6,8658,529 80.5%   
Gross profit Rs m1,1312,539 44.5%  
Depreciation Rs m12874 173.4%   
Interest Rs m39812 3,235.8%   
Profit before tax Rs m6262,698 23.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m121587 20.6%   
Profit after tax Rs m4552,111 21.6%  
Gross profit margin %16.530.6 53.9%  
Effective tax rate %19.321.7 88.9%   
Net profit margin %6.625.5 26.1%  
BALANCE SHEET DATA
Current assets Rs m4,9044,318 113.6%   
Current liabilities Rs m3,5811,143 313.3%   
Net working cap to sales %19.338.3 50.4%  
Current ratio x1.43.8 36.3%  
Inventory Days Days12421 604.7%  
Debtors Days Days10014 700.8%  
Net fixed assets Rs m1,6891,734 97.4%   
Share capital Rs m262148 177.6%   
"Free" reserves Rs m2,3584,777 49.4%   
Net worth Rs m2,6354,925 53.5%   
Long term debt Rs m5070-   
Total assets Rs m6,8626,075 113.0%  
Interest coverage x2.6220.3 1.2%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.4 73.1%   
Return on assets %12.434.9 35.6%  
Return on equity %17.342.9 40.3%  
Return on capital %31.055.0 56.3%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273157 174.3%   
Fx outflow Rs m225 8.2%   
Net fx Rs m271132 205.1%   
CASH FLOW
From Operations Rs m-3131,801 -17.4%  
From Investments Rs m-489368 -132.6%  
From Financial Activity Rs m769-2,156 -35.7%  
Net Cashflow Rs m-3313 -255.9%  

Share Holding

Indian Promoters % 25.5 66.9 38.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 1.6 564.4%  
FIIs % 0.0 24.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 7.1 919.7%  
Shareholders   13,061 19,219 68.0%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   LINC PEN & PLASTICS LTD  ARCHIES LTD  RELAXO FOOTWEARS  EMAMI LTD  MARICO LTD  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views on News

BAJAJ CORP Announces Quarterly Results (1QFY19); Net Profit Down 2.2% (Quarterly Result Update)

Jul 26, 2018 | Updated on Jul 26, 2018

For the quarter ended June 2018, BAJAJ CORP has posted a net profit of Rs 538 m (down 2.2% YoY). Sales on the other hand came in at Rs 2 bn (up 12.1% YoY). Read on for a complete analysis of BAJAJ CORP's quarterly results.

BAJAJ CORP Announces Quarterly Results (4QFY18); Net Profit Up 5.2% (Quarterly Result Update)

Jul 19, 2018 | Updated on Jul 19, 2018

For the quarter ended March 2018, BAJAJ CORP has posted a net profit of Rs 554 m (up 5.2% YoY). Sales on the other hand came in at Rs 2 bn (up 8.3% YoY). Read on for a complete analysis of BAJAJ CORP's quarterly results.

Bajaj Corp: Slow Recovery from GST Implementation (Quarterly Results Update - Detailed)

Nov 10, 2017

A slow recovery from GST implementation and strained wholesale volumes puts pressure on Bajaj Corp's revenues.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS